We’re delighted to announce another patent approval for Valita®Titer, the industry’s fastest IgG quantification assay. Valita®Titer can now quantify up to 1.5 g/L of antibody. The patent represents another important milestone in our growth plan and our determination to protect our technology.
Valita®Titer Patent approval – EU
Want to talk about our products?
Hi, I’m Eligio, Business Development Manager at ValitaCell. Fill in the form to the right and I’ll get in touch with you soon!